CLARUS THERAPEUTICS HOLDINGS, INC. Earnings Per Share, Basic and Diluted
CLARUS THERAPEUTICS HOLDINGS, INC. reported Earnings Per Share, Basic and Diluted of -$0.61 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-16
- CLARUS THERAPEUTICS HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.61.
- CLARUS THERAPEUTICS HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.58.
- CLARUS THERAPEUTICS HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was $0.00.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 7 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.61 10-Q · filed 2022-05-16 | |||
| 2021-06-30 | -$0.58 10-Q · filed 2021-08-16 | $1.96 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $2.83 10-Q · filed 2021-05-26 | ||
| 2020-12-31 | -$3.26 10-K · filed 2021-05-06 |